HYPR
Hyperfine Inc - Ordinary Shares - Class A

1,123
Mkt Cap
$113.87M
Volume
465,048.00
52W High
$2.22
52W Low
$0.5327
PE Ratio
-2.34
HYPR Fundamentals
Price
$1.25
Prev Close
$1.23
Open
$1.25
50D MA
$1.43
Beta
1.55
Avg. Volume
332,425.71
EPS (Annual)
-$0.5623
P/B
2.75
Rev/Employee
$116,126.13
Loading...
Loading...
News
all
press releases
Hyperfine Announces Pricing of $17.5 Million Public Offering
Hyperfine, Inc. (Nasdaq: HYPR) (Hyperfine or the Company) today announced it has priced its previously announced underwritten public offering of 14,000,000 shares of the Companys Class A common stock...
Business Wire·7d ago
News Placeholder
More News
News Placeholder
Hyperfine Announces Proposed Public Offering
Hyperfine, Inc. (Nasdaq: HYPR) (Hyperfine or the Company) today announced that it has commenced an underwritten public offering of its Class A common stock or, in lieu of Class A common stock to...
Business Wire·8d ago
News Placeholder
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop System
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop...
Business Wire·8d ago
News Placeholder
Hyperfine Swoop System Referenced in Frances Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop...
Business Wire·10d ago
News Placeholder
Hyperfine (HYPR) Upgraded to Buy: Here's Why
Hyperfine (HYPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
News Placeholder
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and -7.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of -9.09% and -22.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +3.45% and +0.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates
Delcath Systems (DCTH) delivered earnings and revenue surprises of +250.00% and +9.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop System Powered by Optive AI Software
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop...
Business Wire·3mo ago

Latest HYPR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.